The R&D pipeline reflects our long-term commitment to driving change to defeat obesity, haemophilia, growth disorders and other serious chronic diseases
Facts and figures specific to our Research & Development organisation
How we report our financial, social and environmental performance
What guides the way we do business
How we contribute to the Sustainable Development Goals
Photographer Jesper Westley captures the many faces of the global diabetes pandemic.
See the portraits
Mads Krogsgaard Thomsen, CSO of Novo Nordisk, considers the potential of stem cell-based therapies to cure type 1 diabetes and other chronic diseases
Read Mads’ perspective
Features and points of view from Novo Nordisk and the society we serve
Explore our Perspectives
Subscribe to Perspectives
Read more about the issue
28 Jun 2018
23 Jun 2018
For jobs in the United States, please visit our US career site.